A Research Study, Looking at How Ryzodeg® (Insulin Degludec/Insulin Aspart) Works in People With Type 2 Diabetes in Local Clinical Practice

Clinical trial NCT04042441 · COMPLETED

Trial details

NCT number: NCT04042441
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetes Mellitus, Type 2

Start date: 2019-07-29
Primary completion: 2020-12-11
Enrollment: 1122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.